Milestone meeting with Reliance Life Sciences at our Dubai office

Today TheSAY was elated to have delegates from Reliance Life Sciences who have the highest number of biosimilars under development globally.

We held a productive discussion around business expansion in the CIS & African markets and creating a detailed plan for future vaccine projects with Reliance.

In attendance were, KV Subramaniam (CEO), KV Balasubramaniam (Advisor - vaccines), Muthukrishnan R (Regional Head- ME & Africa) & Sivaraman Vasudevan (Vice President- International Business) from Reliance Life Sciences, along with our Dr. Noushad Abdurahiman M.D.(CEO), Balaji Anbalagan (Pharma Director)